Skip to content

Drug interactions

Ethotoin + Nateglinide

Severity: Minor

Ethotoin and Nateglinide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs are linked to CYP2C9 metabolism, but nateglinide is a weak inhibitor at most and ethotoin is not primarily a CYP2C9 substrate. A clinically meaningful rise in ethotoin levels is not established and is largely theoretical.

What this interaction means in plain words

Ethotoin and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Theoretical CYP2C9 competition; no established mechanism for a clinically relevant effect.

What to do

No routine adjustment is needed. Watch for signs of ethotoin toxicity or seizure change if either drug is started or stopped.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ethotoin and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ethotoin with Nateglinide?

MediHelp rates the interaction as minor. Ethotoin and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Both drugs are linked to CYP2C9 metabolism, but nateglinide is a weak inhibitor at most and ethotoin is not primarily a CYP2C9 substrate. A clinically meaningful rise in ethotoin levels is not established and is largely theoretical.

How serious is the interaction between Ethotoin and Nateglinide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed. Watch for signs of ethotoin toxicity or seizure change if either drug is started or stopped.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in